HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Personal Folders Download to citation manager Permission Requests Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Blyth, D. F. Search for Related Content PubMed PubMed Citation Articles by Blyth, D. F.

Eur J Cardiothorac Surg 2000;18:429-434
© 2000 Elsevier Science NL

Pneumonectomy for inflammatory lung disease

Department of Cardio-thoracic Surgery, University of Natal Medical School, Durban, South Africa

Received 7 September 1999; received in revised form 19 May 2000; accepted 28 June 2000.

Tel.: +27-31-4605-112/3; fax: +27-31-461-1724
e-mail: blyth{at}wwh.und.ac.za

Objective: Recent surgical literature has highlighted the dangers of pneumonectomy for inflammatory lung disease; therefore the assessment of the risk/benefit ratio of our departmental policy. Methods: Patients undergoing pneumonectomy for inflammatory lung disease during two 2-year periods, 1991–1992 and 1996–1997 inclusive, were retrospectively analyzed. Clinical indications for investigation and surgery, and radiographic findings were determined. Some comparisons between the two periods were drawn. Rates of morbidity and mortality were the principle outcome measures. Results: One hundred and fifty-five patients, 116 males, 39 females, with an average age of 30.2 years ranging from 1–68 years, underwent pneumonectomy for ongoing features of productive cough, haemoptysis (two emergencies) and chronic empyema all with either bronchographic or computed tomography (CT) evidence of destroyed lung. One hundred and fourteen (72%) had or had had tuberculosis at time of surgery. Histology showed bronchiectasis in 53 (34%), end-stage disease in 49 (31.6%) and active tuberculosis in 48 (30.9%). Over 90% of the patients were free of disease at discharge. Mortality was two (1.2%). Morbidity (23%) included post-pneumonectomy empyema 23 (14.8%), bleeding three (1.9%), broncho-pleural fistula three (1.9%), with wound sepsis in one (0.6%) and thoracic duct injury in one (0.6%). Three groups were identified, (1) pneumonectomy through empyema – a risk group, (2) pneumonectomy in active tuberculosis and (3) pneumonectomy in children. Twenty-three post-pneumonectomy empyemas (PPE) occurred with 21 of these following pneumonectomies through empyema (PTE), six PPEs followed 27 PTEs for active tuberculosis. Fourteen of the 21 empyemas following pneumonectomy through empyema were initially sterilized. Finally 15/23 (65%) of all PPEs were sterilized. Pneumonectomy in active tuberculosis did not carry the mortality or morbidity experienced by others. Pneumonectomy in children was remarkably uncomplicated, with one PPE occurring. Conclusions: This ongoing study shows pneumonectomy for inflammatory lung to be safe, with good results. Tuberculosis, being so common, adequate pre-operative and operative cover with anti-tuberculosis drugs may enhance results.

Key Words: Pneumonectomy • Inflammatory lung disease • Pneumonectomy through empyema

This article has been cited by other articles:

				T. F. Molnar Current surgical treatment of thoracic empyema in adults Eur. J. Cardiothorac. Surg., September 1, 2007; 32(3): 422 - 430. [Abstract] [Full Text] [PDF]

				R. Naidoo Active Pulmonary Tuberculosis: Experience with Resection in 106 Cases Asian Cardiovasc Thorac Ann, April 1, 2007; 15(2): 134 - 138. [Abstract] [Full Text] [PDF]

				A. Shaw Genetics of postoperative complications following thoracic surgery. Seminars in Cardiothoracic and Vascular Anesthesia, December 1, 2006; 10(4): 327 - 345. [Abstract] [PDF]

				R. Naidoo and A. Reddi Lung Resection for Multidrug-Resistant Tuberculosis Asian Cardiovasc Thorac Ann, June 1, 2005; 13(2): 172 - 174. [Abstract] [Full Text] [PDF]

				S. Eren, M. N. Eren, and A. E. Balci Pneumonectomy in children for destroyed lung and the long-term consequences J. Thorac. Cardiovasc. Surg., August 1, 2003; 126(2): 574 - 581. [Abstract] [Full Text] [PDF]

				Y. T. Kim, H. K. Kim, S.-W. Sung, and J. H. Kim Long-term outcomes and risk factor analysis after pneumonectomy for active and sequela forms of pulmonary tuberculosis Eur. J. Cardiothorac. Surg., May 1, 2003; 23(5): 833 - 839. [Abstract] [Full Text] [PDF]

				D.F. Blyth, N.J. Buckels, R. Sewsunker, and M.A. Soni Pneumonectomy in children Eur. J. Cardiothorac. Surg., October 1, 2002; 22(4): 587 - 594. [Abstract] [Full Text] [PDF]

				D. Schneiter, P. Kestenholz, A. Dutly, S. Korom, U. Giger, D. Lardinois, and W. Weder Prevention of recurrent empyema after pneumonectomy for chronic infection Eur. J. Cardiothorac. Surg., April 1, 2002; 21(4): 644 - 648. [Abstract] [Full Text] [PDF]

				M. A. Bedirhan, A. Turna, N. Yagan, and O. Tasci Aprotinin reduces postoperative bleeding and the need for blood products in thoracic surgery: results of a randomized double-blind study Eur. J. Cardiothorac. Surg., December 1, 2001; 20(6): 1122 - 1127. [Abstract] [Full Text] [PDF]